These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 23752610

  • 1. Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice.
    Yeh LT, Miaw SC, Lin MH, Chou FC, Shieh SJ, Chuang YP, Lin SH, Chang DM, Sytwu HK.
    J Immunol; 2013 Jul 15; 191(2):594-607. PubMed ID: 23752610
    [Abstract] [Full Text] [Related]

  • 2. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.
    Verdaguer J, Yoon JW, Anderson B, Averill N, Utsugi T, Park BJ, Santamaria P.
    J Immunol; 1996 Nov 15; 157(10):4726-35. PubMed ID: 8906855
    [Abstract] [Full Text] [Related]

  • 3. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA, Tritt M, Sgouroudis E, Albanese A, Pyzik M, Hay V.
    Ann N Y Acad Sci; 2005 Jun 15; 1051():72-87. PubMed ID: 16126946
    [Abstract] [Full Text] [Related]

  • 4. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.
    Transplantation; 2009 Jan 27; 87(2):198-206. PubMed ID: 19155973
    [Abstract] [Full Text] [Related]

  • 5. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S, Penna G, Gregori S, Chapman HD, Serreze DV, Magram J, Adorini L.
    J Immunol; 1999 Sep 01; 163(5):2960-8. PubMed ID: 10453045
    [Abstract] [Full Text] [Related]

  • 6. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
    Kägi D, Ho A, Odermatt B, Zakarian A, Ohashi PS, Mak TW.
    J Immunol; 1999 Apr 15; 162(8):4598-605. PubMed ID: 10201999
    [Abstract] [Full Text] [Related]

  • 7. The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes.
    Balasa B, Van Gunst K, Sarvetnick N.
    Clin Immunol; 2000 May 15; 95(2):93-8. PubMed ID: 10779402
    [Abstract] [Full Text] [Related]

  • 8. Graded attenuation of TCR signaling elicits distinct autoimmune diseases by altering thymic T cell selection and regulatory T cell function.
    Tanaka S, Maeda S, Hashimoto M, Fujimori C, Ito Y, Teradaira S, Hirota K, Yoshitomi H, Katakai T, Shimizu A, Nomura T, Sakaguchi N, Sakaguchi S.
    J Immunol; 2010 Aug 15; 185(4):2295-305. PubMed ID: 20644168
    [Abstract] [Full Text] [Related]

  • 9. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
    Zhang Y, Lee AS, Shameli A, Geng X, Finegood D, Santamaria P, Dutz JP.
    J Immunol; 2010 May 15; 184(10):5645-53. PubMed ID: 20393135
    [Abstract] [Full Text] [Related]

  • 10. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
    Tritt M, Sgouroudis E, d'Hennezel E, Albanese A, Piccirillo CA.
    Diabetes; 2008 Jan 15; 57(1):113-23. PubMed ID: 17928397
    [Abstract] [Full Text] [Related]

  • 11. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
    You S, Slehoffer G, Barriot S, Bach JF, Chatenoud L.
    Proc Natl Acad Sci U S A; 2004 Oct 05; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
    [Abstract] [Full Text] [Related]

  • 12. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
    Shieh SJ, Chou FC, Yu PN, Lin WC, Chang DM, Roffler SR, Sytwu HK.
    J Immunol; 2009 Aug 15; 183(4):2277-85. PubMed ID: 19635924
    [Abstract] [Full Text] [Related]

  • 13. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    Kornete M, Mason ES, Girouard J, Lafferty EI, Qureshi S, Piccirillo CA.
    PLoS One; 2015 Aug 15; 10(5):e0126311. PubMed ID: 25946021
    [Abstract] [Full Text] [Related]

  • 14. PTPN22 controls virally-induced autoimmune diabetes by modulating cytotoxic T lymphocyte responses in an epitope-specific manner.
    Fousteri G, Jofra T, Di Fonte R, Kuka M, Iannacone M, Battaglia M.
    Clin Immunol; 2015 Feb 15; 156(2):98-108. PubMed ID: 25513733
    [Abstract] [Full Text] [Related]

  • 15. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse.
    Herbelin A, Gombert JM, Lepault F, Bach JF, Chatenoud L.
    J Immunol; 1998 Sep 01; 161(5):2620-8. PubMed ID: 9725264
    [Abstract] [Full Text] [Related]

  • 16. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH, Lee WH, Ortiz S, Lee MH, Qin HJ, Liu CP.
    Diabetes; 2009 Jan 01; 58(1):146-55. PubMed ID: 18984738
    [Abstract] [Full Text] [Related]

  • 17. CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity.
    Mayer CT, Floess S, Baru AM, Lahl K, Huehn J, Sparwasser T.
    Eur J Immunol; 2011 Mar 01; 41(3):716-25. PubMed ID: 21312192
    [Abstract] [Full Text] [Related]

  • 18. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
    Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P.
    J Clin Invest; 2000 Feb 01; 105(4):459-68. PubMed ID: 10683375
    [Abstract] [Full Text] [Related]

  • 19. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
    Han HS, Jun HS, Utsugi T, Yoon JW.
    J Autoimmun; 1996 Jun 01; 9(3):331-9. PubMed ID: 8816968
    [Abstract] [Full Text] [Related]

  • 20. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M, Yoshimoto K, Wong SF, Tanaka C, Yamaoka T, Sano T, Komagata Y, Miyazaki J, Kikutani H, Itakura M.
    J Clin Invest; 1998 Aug 01; 102(3):499-506. PubMed ID: 9691086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.